C1512474||Histone deacetylase inhibitors
C0242643||P-gp
C1171362||expression
C1527249||colorectal cancer
C0162493||transcriptional activation
C1327287||mRNA stabilization
C1512474||Histone deacetylase inhibitors
C1512474||Histone deacetylase inhibitors
C0456387||class
C0003392||anti-tumor drugs
C1512474||Histone deacetylase inhibitors
C0027651||tumors
C0087111||treatment
C0013203||resistance
C1512474||Histone deacetylase inhibitors
C2603343||study
C1512474||Histone deacetylase inhibitors
C0672708||SAHA
C0077063||TSA
C0242643||P-gp
C1171362||expression
C0334227||CRC cells
C0282588||drug resistant
C1512474||Histone deacetylase inhibitors
C0040649||transcriptional activity
C0242643||P-gp
C0376622||protein encoding gene ABCB1
C1512474||Histone deacetylase inhibitors
C0087111||treatment
C0033684||protein
C0017262||mRNA expression
C0253050||STAT3
C1744349||PXR
C0663285||CAR
C1333633||Foxo3a
C0105770||Î²-catenin
C1158770||ABCB transcription regulation
C2350567||knockdown
C0253050||STAT3
C1512474||Histone deacetylase inhibitors
C0242643||P-gp
C0041904||up-regulation
C0334227||colorectal cancer cells
C0253050||STAT3
C1512474||Histone deacetylase inhibitors
C0041904||up-regulated
C0242643||P-gp
C2603343||study
C1512474||Histone deacetylase inhibitors
C1257825||stability of ABCB1
C0035684||post-transcriptional level
C1512474||Histone deacetylase inhibitors
C0242643||P-gp
C1171362||expression
C0162493||transcriptional activation
C1327287||mRNA stabilization
C0920425||cancer treatment
C1512474||Histone deacetylase inhibitors
C0334227||cancer cells